FMC Corporation filings document the regulatory record of a NYSE-listed agricultural sciences company with common stock trading under FMC. Recent 8-K reports disclose operating results, material credit-agreement amendments, financial covenants, subsidiary guarantees, collateral arrangements, dividend limitations, restructuring charges, and governance changes.
Proxy materials describe annual meeting matters, stockholder voting procedures, and equity incentive plan approvals. Together, the filings cover FMC's capital structure, board oversight, compensation programs, manufacturing footprint actions, risk-related covenant terms, and recurring financial reporting for its crop protection business.
CORDEIRO EDUARDO E reported acquisition or exercise transactions in this Form 4 filing.
FMC Corp director Eduardo E. Cordeiro reported the issuance of 131 shares of common stock on 2026-07-16. These shares were granted at $0.0000 per share pursuant to dividend equivalent rights tied to vested restricted stock units, raising his direct holdings to 41,011 shares.
DAVIDSON CAROL ANTHONY reported acquisition or exercise transactions in this Form 4 filing.
FMC Corp director Carol Anthony Davidson received a grant of 83 shares of Common Stock on 2026-07-16. The shares were issued at no cash cost as dividend equivalent rights tied to vested restricted stock units. Following this award, Davidson directly owns 32,574 FMC shares.
Fortmann Kathy Lynn reported acquisition or exercise transactions in this Form 4 filing.
Kathy Lynn Fortmann, a director of FMC Corp, reported receiving a grant of 101 shares of common stock on July 16, 2026. These shares were issued as dividend equivalent rights tied to vested restricted stock units. After this award, she directly holds 23,653 FMC shares.
FMC Corp director Johnson KLynne reported an acquisition of 184 shares of Common Stock on 2026-07-16. The shares were issued at $0.0000 per share pursuant to dividend equivalent rights tied to vested restricted stock units, increasing direct holdings to 44,535 shares.
FMC Corp director Michael F. Barry reported an acquisition of 11 shares of common stock on July 16, 2026. The shares were issued at no cash cost pursuant to dividend equivalent rights tied to his vested restricted stock units. Following this award, he directly holds 28820.1910 shares.
FMC Corp reported that director John Mitchell Raines acquired 48 shares of Common Stock on July 16, 2026 through dividend equivalent rights tied to vested restricted stock units, at a stated price of $0.00 per share. Following this award, he directly holds 23,044 shares.
MERKT STEVEN T reported acquisition or exercise transactions in this Form 4 filing.
FMC Corp director Steven T. Merkt received a grant of 41 shares of common stock on July 16, 2026. The shares were issued at $0.00 per share pursuant to dividend equivalent rights tied to vested restricted stock units, increasing his direct holdings to 15,094 shares.
Verduin Patricia reported acquisition or exercise transactions in this Form 4 filing.
FMC Corp director Patricia Verduin received a grant of 50 shares of FMC common stock on 2026-07-16 at $0.00 per share. According to the footnote, the shares were issued pursuant to dividend equivalent rights tied to vested restricted stock units. After this award, she directly owns 16,376 shares of FMC common stock.
FMC Corporation agreed to a strategic minority equity investment from Tessenderlo Group, which will purchase 30,319,166 FMC common shares at $13.30 per share for an aggregate $403,244,907.80. After closing, Tessenderlo is expected to hold about 20.0% of FMC’s outstanding stock, pending customary regulatory approvals.
At closing, Tessenderlo will gain one board seat and a board observer while committing to vote its shares with the board’s recommendations on most matters, observe standstill restrictions, and accept a 36‑month lock‑up on transfers, subject to exceptions. FMC plans to use the proceeds to pay down debt toward its approximately $1 billion debt reduction target, supporting its strategy to operate independently while advancing its R&D pipeline and commercialization plans.
FMC Corporation and certain subsidiaries entered into Amendment No. 7 to their Fifth Amended and Restated Credit Agreement originally dated June 17, 2022. The amendment changes the limitation on liens in the credit facility and releases security interests on certain collateral that previously secured the company’s obligations.
The agreement continues to involve Citibank, N.A. as administrative agent and a syndicate of lenders and issuing banks. Some of these lenders and their affiliates also provide FMC with other financial services, including cash management, investment banking, trust and leasing services, as well as interest rate and foreign exchange arrangements.